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Abstract
Glucose uptake is autoregulated in a variety of cell types and it is thought that glucose transport is the major step that is
subjected to control by sugar availability. Here, we examined the effect of high glucose concentrations on the rate of glucose
uptake by human ECV-304 umbilical vein-derived endothelial cells. A rise in the glucose concentration in the medium led a
dose-dependent decrease in the rate of 2-deoxyglucose uptake. The effect of high glucose was independent of protein
synthesis and the time-course analysis indicated that it was relatively slow. The effect was not due to inhibition of glucose
transport since neither the expression nor the subcellular distribution of the major glucose transporter GLUT1, nor the rate
of 3-O-methylglucose uptake was affected. The total in vitro assayed hexokinase activity and the expression of hexokinase-I
were similar in cells treated or not with high concentrations of glucose. In contrast, exposure of cells to a high glucose
concentration caused a marked decrease in phosphorylated 2-deoxyglucose/free 2-deoxyglucose ratio. This suggests the
existence of alterations in the rate of in vivo glucose phosphorylation in response to high glucose. In summary, we conclude
that ECV304 human endothelial cells reduce glucose utilization in response to enhanced levels of glucose in the medium by
inhibiting the rate of glucose phosphorylation, rather than by blocking glucose transport. This suggests a novel metabolic
effect of high glucose on cellular glucose utilization. ß 1999 Elsevier Science B.V. All rights reserved.
Keywords: GLUT1 glucose transporter; Endothelial cell ; Hexokinase; Glucose uptake; ECV-304 cell
1. Introduction
Endothelial cells are involved in the development
of both micro- and macroangiopathy during diabe-
tes. The early microvascular lesions of diabetic mi-
croangiopathy are characterized by thickened capil-
lary basement membranes, increased vascular
permeability and selective disappearance of pericytes
from the retinal capillaries [1]. Increasing evidence
indicates that high glucose concentrations are re-
sponsible for diabetic microangiopathy. Thus, in-
creased width of retinal capillary basement mem-
branes and a pattern of diabetic-like retinopathy
can be induced by hyperhexosemia unaccompanied
by other metabolic abnormalities [2]. Furthermore,
human endothelial cells incubated in the presence
of high concentrations of glucose show enhanced
mRNA levels for collagen IV, laminin B and ¢bro-
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nectin, which remain high after several cell divisions
in the presence of normal glucose concentrations
[3^5]. The capacity of endothelial cells to proliferate
is also reduced in the presence of high glucose con-
centrations [6]. Among the mechanisms that have
been postulated to mediate the e¡ects of high glucose
concentrations on the metabolism and proliferation
of the endothelial cells, we could mention the metab-
olism of sorbitol [1,7], activation of protein kinase C,
reduction in phosphatidylinositide metabolism, pro-
duction of free radicals or non-enzymatic protein
glycosylation [7].
There is substantial evidence that glucose trans-
port is autoregulated in cells, and hyperglycemia is
believed to regulate glucose transport by peripheral
tissues in vivo [8]. High glucose concentrations cause
inhibition of glucose transport as a consequence of a
reduction in the number of glucose transporters
present at the cell surface. This e¡ect has been de-
scribed in myoblasts [9,10], adipocytes 3T3-L1 [11],
glial cells [12], ¢broblasts [13], renal cells [14] and in
skeletal muscle [15]. The mechanisms responsible for
the autoregulation of glucose transport depend on
the tissue or cell type studied; it has been reported
that high glucose reduces GLUT1 mRNA levels
[16,17], GLUT1 protein content [18,19], or the num-
ber of GLUT1 glucose transporters present at the
cell surface [16,20].
Several studies have reported a reduction of glu-
cose uptake by the endothelium in diabetes [21^23].
However, the mechanisms have not been studied.
Here we have examined the e¡ect of high glucose
concentrations on the glucose uptake by ECV304
human endothelial cells, which derive from human
umbilical vein. Our results indicate that high glucose
leads to inhibition of glucose uptake which is due to
inhibition of glucose phosphorylation. This report
substantiates a novel metabolic e¡ect of high glucose
on glucose handling by cells.
2. Materials and methods
2.1. Materials
[125I]protein A and [K-32P]dCTP were purchased
from ICN. Hybond N was from Amersham and ran-
dom primed DNA labeling kit was from Boehringer.
Immobilon was obtained from Millipore. All electro-
phoresis reagents and molecular weight markers were
obtained from Bio-Rad and BRL. Gamma-globulin
and most commonly used chemicals were from
Sigma. ECV304 human umbilical vein cell line
was obtained from ECACC and from Dr. Kimiko
Takahashi (National Defense Medical College,
Namiki, Japan). Medium 199, FBS, glutamine and
antibiotics were obtained from Whittaker (Walkers-
ville, MD).
2.2. Cell culture
ECV304 endothelial cells were grown in medium
199, containing 10% (v/v) fetal bovine serum (FBS),
1% (v/v) antibiotics (10 000 U/ml penicillin G and 10
mg/ml streptomycin), 2 mM glutamine and 25 mM
HEPES (pH 7.4) and di¡erent concentrations of glu-
cose. Di¡erences in the concentration of glucose in
the medium were compensated by the addition of
mannitol.
Bovine aortic endothelial cells (BAEC) were iso-
lated as previously described [24] from aortas of
freshly slaughtered calves. Aortas were cut length-
wise and washed with phosphate-bu¡ered saline
(140 mM NaCl, 4 mM KCl, 1 mM Na2HPO4,
1 mM KH2PO4, and 12 mM glucose, pH 7.4). The
adventitia were removed, and the remaining part of
intima and media was clamped into the aluminum
frame of a small tub. The intima with the endothe-
lium built the bottom of the tub, which was ¢lled
with 5 ml dispase solution (0.5 mg/ml). After 15
min of incubation at 37‡C, the enzyme solution
was removed, and the endothelial cells were collected
by washing the intima with 6 ml Dulbecco’s modi¢ed
Eagle’s medium (DMEM) containing fetal calf serum
at a ¢nal concentration of 20%. The cells were plated
on three 35-mm wells that were pretreated with 0.2%
gelatin solution for 30 min at room temperature. The
next day, the cells were washed with DMEM and
cultured with 10% FCS-DMEM at 37‡C in an incu-
bator with 5% CO2^95% air atmosphere. Subcultures
were carried out removing the cells with trypsin sol-
ution (0.5 mg/ml) from the bottom of the well, spin-
ning them down at 100Ug for 10 min, and plating
them again (dilution 1:7).
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2.3. Glucose uptake
ECV304 cells were cultured in six-well dishes and
grown to con£uence. At the indicated times after
di¡erent glucose concentrations in the medium, cells
were washed, and ‘transport bu¡er’ (20 mM HEPES,
150 mM NaCl, 5 mM KCl, 5 mM MgSO4, 1.2 mM
KH2PO4, 2.5 mM CaCl2, 2 mM pyruvate, pH 7.4)
was added, together with 100 WM 2-deoxy-D-
[3H]glucose (96 mCi/mmol). After 10 min, transport
was stopped by addition of 2 vols. of ice-cold 50 mM
glucose in PBS. Cells were washed three times in the
same solution and disrupted with 0.1 M NaOH/0.1%
SDS. Radioactivity was determined by scintillation
counting. Protein was determined by the Bradford
method [25]. Each condition was run in duplicate,
and the non-speci¢c uptake (t = 0) was determined
by incubation of the 2-deoxy-D-[3H]glucose in stop
solution (50 mM glucose in PBS) instead of transport
solution. In all cases, the value at t = 0 represented
4% of the basal transport activity at t = 20 min.
In some experiments, free (unionized species) and
phosphorylated [3H]2-deoxyglucose (ionized species)
were separated by ion exchange chromatography on
2-ml bed volume of Dowex 1-X8 (acetate form) col-
umns. To this end, cell extracts were deproteinized in
5% perchloric acid and further neutralized with a
0.5 M triethanolamine 2 M KOH solution. Columns
were loaded with neutralized extracts and the union-
ized species were obtained by elution with 2 ml of
distilled water; the ionized species were obtained
after addition of 3 ml of 2 M HCl. Recoveries of
added ionized and unionized material were s 90%
with negligible misclassi¢cation using this methodol-
ogy.
In some experiments, 3-O-methyl-glucose uptake
was assayed; to this end, cells previously cultured
with 5.5 or 22 mM glucose were incubated in
‘transport bu¡er’ together with 100 WM 3-O-[meth-
yl-14C]glucose (96 mCi/mmol) for 0.5 or 1 min, and
stopped as described above. Control studies showed
that, under our experimental conditions, 3-O-meth-
ylglucose uptake was linear during the ¢rst 2 min
of uptake. Culture of cells with 5.5 or 22 mM
glucose did not alter the extracellular water space
as assessed by L-[1-14C]glucose distribution (data
not shown) which was accounted for by 0.4 Wl/
106 cells.
2.4. Hexokinase activity
Hexokinase was assayed by the glucose-6-phos-
phate dehydrogenase method. We measured the
absorbance change at 340 nm due to NADPH for-
mation coupled with 6-phosphogluconolactone for-
mation from glucose-6-phosphate catalyzed by glu-
cose-6-phosphate dehydrogenase in the presence of
glucose and ATP [26]. For this, ECV304 cells prein-
cubated for 24 h with 5.5 or 25 mM glucose were
scraped in 1 ml ice-cold bu¡er containing 10 mM
Tris-HCl, 150 mM NaCl, 5 mM KCl, pH 7.4, and
sonicated in a Vibra Cell cell disrupter (Bioblock
Scienti¢c) three times for 10 s at 75% output, and
centrifuged 5 min at 14,000 rpm. Amounts of 25 Wg
of extract were added to 50 mM Tris-HCl bu¡er (pH
7.6), 15 mM MgCl2, 1 mM NADP, 5 mM ATP,
0.4 U/ml glucose-6-phosphate dehydrogenase, and
various concentrations of glucose. From the absorb-
ance changes the values of Km and Vmax were deter-
mined.
2.5. Preparation of total membrane fractions
Cells were washed twice in PBS, scraped and ho-
mogenized in 2 ml ice-cold bu¡er containing 25 mM
HEPES, 250 mM sucrose, 4 mM EDTA, 1 trypsin
inhibitor U/ml aprotinin, 25 mM benzamidine, 0.2
mM PMSF, 1 WM leupeptin and 1 WM pepstatin,
pH 7.4, using a Dounce A. After homogenization,
the cell suspension was centrifuged for 10 min at
750Ug at 4‡C. The supernatants were then centri-
fuged at 200 000Ug for 90 min at 4‡C to obtain
the membrane fractions. The membrane pellets
were resuspended in homogenization bu¡er and re-
peatedly passed through a 25-gauge needle before
storage at 320‡C. Proteins were measured by the
method of Bradford [25] using gamma-globulin as
a standard.
2.6. Subcellular membrane fractionation
ECV304 endothelial cells were fractionated by a
modi¢cation of the method described by Horner et
al. [27]. Cells were cultured in 150-cm2 culture dishes
and grown to con£uence. After washing with PBS,
cells were scraped in 2-ml ice cold homogenization
bu¡er (25 mM HEPES, 250 mM sucrose, 4 mM
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EDTA, 1 trypsin inhibitor U/ml aprotinin, 25 mM
benzamidine, 0.2 mM PMSF, 1 WM leupeptin and
1 WM pepstatin, pH 7.4). The cell content of the
di¡erent dishes was pooled and homogenized with
ten strokes in a glass homogenizer (Heidolph, setting
5). The lysate was centrifuged at 16 000Ug for 15
min. The pellet (fraction HT) was resuspended in
2 ml of HEPES 30 mM, sucrose 10% (w/v), pH
7.6, layered on top of a discontinuous density gra-
dient consisting of 3 ml of 27%, 3 ml of 38%, and
2 ml of 48% (w/v) sucrose and centrifuged at
76 000Ug for 2 h in a TH-641 Sorvall rotor. The
bands at the 10/27 (fraction F1), 27/38 (fraction
F2), and 38/48 (fraction F3) interfaces and the pellet
(fraction F4) were collected. All the fractions were
removed with a plastic pipette, diluted with HEPES
30 mM, pH 7.6, and centrifuged at 70 000Ug for
25 min. The pellets from this centrifugation were
resuspended in 100^200 Wl of HEPES 30 mM, pH
7.6. The supernatant from the 16 000Ug centrifuga-
tion was centrifuged at 150 000Ug for 90 min, and
the resultant pellet (designated S1), was resuspended
in 200 Wl of HEPES 30 mM, pH 7.6. Proteins were
measured by the method of Bradford [25] using gam-
ma-globulin as a standard.
2.7. Deglycosylation of membrane proteins
N-Linked carbohydrates were removed from either
brain cell membranes or ECV 304 cells membranes
by treatment with N-glycosidase F (Boehringer).
Amounts of 10 Wg of membrane proteins were dena-
tured by adding SDS (0.5% ¢nal) to a ¢nal volume of
10 Wl and boiled for 1 min. Solubilized membrane
proteins were incubated overnight at 37‡C, after
the addition of 25 Wl of 0.2 M phosphate bu¡er,
12.5 Wl of 0.2 M EDTA, 2.5 Wl of 10% Triton
X-100, 5 Wl of proteases inhibitors (10 WM pepstatin,
10 WM leupeptin and 10 U/ml aprotinin), and 0.2 U
of N-glycosidase F. After this time, extracts were
treated with Laemmli sample bu¡er, and loaded to
a polyacrylamide gel.
2.8. Total cell lysates
ECV304 cells were washed twice with cold PBS
and lysed in Triton X-100 lysis bu¡er (50 mM Tris-
HCl, pH 7.5, 100 mM NaCl, 50 mM NaF, 5 mM
EDTA, 40 mM L-glycerophosphate, 200 WM sodium
orthovanadate, 1034 M phenylmethyl-sulfonyl £uo-
ride, 1 Wg/ml leupeptin, 1 WM pepstatin A, 4 Wg/ml
aprotinin, 1% Triton X-100) for 15 min at 4‡C. In-
soluble material was removed by centrifugation at
12000Ug for 5 min at 4‡C. Proteins were measured
by the method of Bradford [25] using gamma-glob-
ulin as a standard.
2.9. Electrophoresis and immunoblotting of
membranes
Sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis was performed on membrane protein
in accordance with the method of Laemmli [28]. Pro-
teins were transferred to Immobilon as previously
reported [29] in bu¡er consisting of 20% methanol,
200 mM glycine, 25 mM Tris, pH 8.3. Following
transfer, the ¢lters were blocked with 5% non-fat
dry milk, 0.02% sodium azide in PBS for 1 h at
37‡C and incubated with antibodies. Transfer was
con¢rmed by Coomassie blue staining of the gel after
the electroblot. Antibodies against di¡erent proteins
were incubated in 1% non-fat dry milk, 0.02% so-
dium azide in PBS overnight at room temperature.
Polyclonal antibody OSCRX was raised against the
15C-terminal peptide from GLUT4 [30]. Rabbit Bb
antiserum raised against the puri¢ed human erythro-
cyte glucose transporter was a gift of Dr. C. Carter-
Su, University of Michigan. Polyclonal antibody
against the human GLUT3 glucose transporter was
a generous gift of Dr. L.J. Slieker (Lilly, Indianap-
olis, USA) and polyclonal antibody against human
GLUT5 was kindly given by Dr. E. Brot-Laroche
(INSERM U178, Villejuif, France). A rabbit polyclo-
nal antibody against rat L1-integrin was generously
provided by Dr. Carles Enrich (University of Barce-
lona) [31]. Rabbit anti-rat type I hexokinase was a
generous gift from Dr. J.E. Wilson (Michigan State
University). Detection of the immune complex with
the rabbit polyclonal antibodies was accomplished
using [125I]protein A for 4 h at room temperature.
Immunoblots were performed under conditions in
which autoradiographic detection was in the linear
response range.
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2.10. RNA isolation and Northern blot analysis
Total RNA was extracted using the acid guanidi-
nium thiocyanate/phenol/chloroform method as de-
scribed by Chomczynski and Sacchi [32]. All samples
had a 260/280 absorbance ratio above 1.8.
After quanti¢cation, total RNA (30 Wg) was dena-
tured at 65‡C in the presence of formamide, form-
aldehyde and ethidium bromide [33] to allow the
visualization of RNA. RNA was separated on a
1.2% agarose/formaldehyde gel and blotted on Hy-
bond N ¢lters. The RNA in gels and in ¢lters was
visualized with ethidium bromide by UV transillumi-
nation to ensure the integrity of RNA, to check the
loading of equivalent amounts of total RNA and to
con¢rm proper transfer. RNA was transferred in
10Ustandard saline citrate (1USSC is 0.15 NaCl
and 0.015 M sodium citrate, pH 7.0).
Blots were initially prehybridized for 4 h at 45‡C
in 50% formamide, 5UDenhardt’s (1UDenhardt’s
solution is 0.02% polyvinylpyrrolidone, 0.02% Ficoll,
0.02% BSA), 0.1% SDS, 5USSPE (1USSPE is 0.15
M NaCl, 1 mM EDTA and 10 mM NaH2PO4, pH
7.4) and 0.2 mg/ml of denatured salmon sperm
DNA. The blots were then hybridized to the
cDNA probes for 12 h at 42‡C in 50% formamide,
5UDenhardt’s, 0.1% SDS, 5USSPE, 10% dextran
sulfate and 0.2 mg/ml of denatured salmon sperm
DNA. The rat cDNA probe for GLUT1 was a
2521-bp fragment (obtained from Dr. M. Birnbaum,
University of Pennsylvania). The cDNA probe for L-
actin was a 4500-bp HindIII and EcoRI fragment
[34]. The cDNA probes were labeled with [32P]dCTP
by random oligonucleotide-priming. The probes were
included at 2U106 cpm/ml. Filters were washed for
15 min in 2USSC at room temperature, then for 20
min in 0.4USSC, 0.1% SDS at 55‡C and ¢nally for
30 min in 0.1USSC, 0.1% SDS at 55‡C.
3. Results
3.1. High glucose concentrations reduce glucose
uptake in ECV304 cells
In this study, we have used ECV304 cell line as a
model of human endothelial cells. This is a sponta-
neously immortalized human umbilical vein-derived
Fig. 1. E¡ect of glucose on 2-deoxyglucose uptake in ECV304
cells. (A) ECV304 cells were grown to con£uency and were
then incubated for 24 h in medium without serum and in the
presence of di¡erent concentrations of glucose. After this time,
uptake of 2-deoxyglucose was measured for 10 min at 37‡C.
The result was expressed as % of the maximal uptake obtained
with 0 mM glucose in the medium. Results are means þ S.E. of
three experiments, each run on duplicate plates. The uptake of
2-deoxyglucose in cells cultured in the absence of glucose was
8.5 þ 0.9 nmol/mg protein per 10 min. (B) ECV304 cells were
grown to con£uency and then were incubated for 24 h in me-
dium without serum with 5.5 mM glucose (E) or 22 mM glu-
cose (F). After this time, the uptake of 2-deoxyglucose was
measured in the presence of varying concentrations of 2-deoxy-
glucose for 10 min. The results correspond to a representative
experiment from ¢ve independent observations run in duplicate.
The rate of 2-deoxyglucose uptake was expressed as nmol of 2-
deoxyglucose taken up by cell during 10 min per mg of protein.
Statistical analysis demonstrated that regression curves were sig-
ni¢cantly di¡erent in 5.5 mM as compared with 22 mM glucose
at P6 0.05.
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endothelial cell line [35] that maintains many charac-
teristics of endothelial cells such as the expression
Von Willebrand factor or integrin KVL3 (data not
shown) or the formation of tubes in vitro [35^37].
In order to determine the e¡ect of glucose on glu-
cose uptake, ECV304 cells were incubated for 24 h in
a medium with di¡erent concentrations of glucose,
and 2-deoxyglucose uptake was measured. The incu-
bation of cells with increasing levels of glucose led to
a dose-dependent inhibition of hexose uptake (Fig.
1). The maximal e¡ect was obtained near 30 mM,
and the half-maximal e¡ect was obtained at 17 mM
(Fig. 1). The reduction of 2-deoxyglucose uptake at
30 mM glucose was approximately 60% (Fig. 1A).
The e¡ect of high glucose was characterized by a
reduced Vmax values of 2-deoxyglucose uptake with
no changes in Km for 2-deoxyglucose (Fig. 1B). The
e¡ect of high glucose was not due to changes in the
osmotic pressure since the di¡erences in the concen-
tration of glucose were compensated by the addition
of mannitol. A similar inhibitory e¡ect of high glu-
cose concentrations on 2-deoxyglucose uptake was
also observed in bovine aortic endothelial cells
(data not shown).
The e¡ect of high glucose was time-dependent, as
shown in Fig. 2. The maximal inhibition was ob-
tained at 24 h after incubation in the presence of
22 mM glucose, and the semi-maximum e¡ect was
recorded after 6 h (Fig. 2A). We further tested the
reversibility of the e¡ect of glucose on 2-deoxyglu-
cose uptake. To this end, ECV304 cells were exposed
at 22 mM glucose for 24 h, and after this time, cells
were switched to medium containing 5.5 mM glucose
or maintained at 22 mM glucose; 2-deoxyglucose
uptake was measured at di¡erent times after the
switch. In Fig. 2B, we show the percentage of resid-
ual inhibition remaining in the group switched from
22 to 5.5 mM glucose. The e¡ect of 22 mM glucose
was reversible, and the recovery of normal 2-deoxy-
glucose uptake was fast (4 h) and the half-maximal
response was reached within 1 h (Fig. 2B). In this
regard, the e¡ect of glucose on 2-deoxyglucose up-
take is asymmetric since it takes longer to reduce
glucose uptake than to relieve the inhibition after
switching cells from high to low glucose concentra-
tions.
We next determined whether protein synthesis was
required. To this end, cells were incubated in the
presence of 5.5 or 22 mM glucose with or without
5 or 10 Wg of cycloheximide. The reduction of 2-
deoxyglucose uptake induced by 22 mM glucose
was observed both in the absence and in the presence
of the di¡erent concentrations of cycloheximide
tested (data not shown).
Fig. 2. Time dependence and reversibility of the e¡ects of high
glucose on 2-deoxyglucose uptake in ECV304 cells. (A)
ECV304 cells were grown to con£uency at 5.5 mM glucose,
and then switched for the times indicated in medium containing
22 mM glucose. After these times, the uptake of 2-deoxyglucose
was assayed for 10 min. Results are expressed as a percentage
of inhibition and correspond to the average of four independent
experiments, each run on duplicate plates. (B) Cells were grown
to con£uency and were then incubated in medium with 22 mM
glucose for 24 h. After this time, medium was replaced with
fresh medium containing 5.5 glucose and at the times indicated,
uptake of 2-deoxyglucose was measured for 10 min. The results
are expressed as % of the maximal inhibition. A representative
experiment performed in duplicate is shown.
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3.2. High glucose does not modify subcellular
distribution of glucose transporters or glucose
transport in ECV304 cells
In the next step, we examined whether glucose
transport or glucose transporters were modi¢ed by
changes in the concentration of glucose in the me-
dium. Preliminary experiments indicated that
GLUT1 was the major glucose transporter expressed
in ECV304 cells. GLUT1 was highly abundant in
extracts from ECV304 cells ; however GLUT3,
GLUT4 or GLUT5 were not expressed based on
Western blot (Fig. 3) or Northern blot (data not
shown). The protein GLUT1 detected in membrane
fractions obtained from ECV304 cells showed a
greater apparent molecular weight than the one ob-
tained from rat brain (Fig. 3). The di¡erence in elec-
trophoretic mobility between GLUT1 protein ex-
pressed in ECV304 cells and GLUT1 from rat
brain was due to di¡erences in glycosylation, and
similar mobilities were shown after treatment with
endoglycosidase F (Fig. 3).
To determine the basis for the reduction of glucose
uptake in response to high concentrations of glucose,
we performed Northern blot assays from total RNA
obtained from cells incubated for 24 or 48 h in the
presence of 5.5 or 22 mM glucose (Fig. 4A). No
changes in the amount of GLUT1 mRNA were ob-
served after incubation in high glucose concentra-
tions (Fig. 4A) which occurred in the presence of
similar yields of total RNA. In order to examine
whether the e¡ect was due to modi¢cation of the
cellular content of GLUT1 protein, or due to alter-
ations in the subcellular distribution of this trans-
porter, membrane subcellular fractionation was per-
formed, and the amount of the GLUT1 protein was
assayed by Western blot. As shown in Fig. 4B, in-
cubation in the presence of 22 mM glucose was not
associated with any modi¢cation in the total levels of
GLUT1 protein, or in the subcellular distribution of
GLUT1. No alteration in the yield of membrane
proteins was detected after incubation of cells in
the presence of 22 mM glucose (data not shown).
In keeping with the observations in ECV304 cells,
incubation of bovine aortic endothelial cells in the
presence of high glucose did not alter the expression
of GLUT1 protein (data not shown). In all, these
results strongly suggest that the e¡ect of glucose on
glucose uptake is not due to a modi¢cation of glu-
cose transport. To con¢rm this, uptake of 3-O-meth-
ylglucose uptake (a non-metabolizable analog that is
transported, but not phosphorylated) was performed
in ECV304 cells previously incubated for 24 h in high
glucose or low glucose. Under conditions in which 3-
O-methylglucose uptake was linear, the preincuba-
tion with 5.5 or 22 mM glucose did not modify glu-
Fig. 3. ECV304 endothelial cells express GLUT1 glucose trans-
porters. Membrane proteins obtained from ECV304 cells (30
Wg) were laid on gels of 10% polyacrylamide. After blotting,
GLUT1, GLUT3 and GLUT4 proteins were detected by incu-
bation with speci¢c polyclonal antibodies. In the case of
GLUT1, membrane proteins were also incubated in the absence
(3NglycoF) or in the presence (+NglycoF) of N-endoglycosi-
dase F before the load of the gel.
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cose transport (Fig. 5). Furthermore, culture of cells
with 5.5 or 22 mM glucose did not alter the extra-
cellular water space as assessed by radioactive L-glu-
cose distribution (data not shown).
3.3. High glucose does not alter total hexokinase
activity, but reduces the ratio phosphorylated 2-
deoxyglucose/free deoxyglucose in ECV304 cells
2-Deoxyglucose is a non-metabolizable glucose
analog that is transported across the cell membrane
by activity of glucose transporters and it is also phos-
phorylated by hexokinases; however, its metabolism
ends at the 2-deoxyglucose-6-phosphate level. Based
on this and based on previous results indicating that
high glucose reduces 2-deoxyglucose uptake, but not
glucose transport, we next directly assessed whether
the modi¢cations in the uptake of 2-deoxyglucose
were due to alterations in the step of phosphoryla-
tion. First, we measured hexokinase activity from
total lysates from ECV304 cells incubated for 24 h
in presence of 5.5 or 22 mM glucose. No changes in
the Km (0.05 þ 0.02 mM at 5.5 mM and 0.06 þ 0.01
mM at 22 mM glucose) or in the Vmax (0.21 þ 0.06
nmol/Wg protein per min, at 5.5 mM glucose, and
0.24 þ 0.06 nmol/Wg protein per min, at 22 mM glu-
cose). Moreover, no di¡erences were detected in the
total amount of hexokinase-I detected by immuno-
blotting (data not shown). In contrast, when we in-
cubated ECV304 cells for 10 min in the presence of
[3H]2-deoxyglucose, and thereafter, we have meas-
ured the levels of free 2-deoxyglucose or phosphoryl-
ated 2-deoxyglucose, we detected that the preincu-
bation with 22 mM glucose for 24 h caused a 41%
reduction in 2-deoxyglucose uptake (Fig. 6). Under
these conditions, free 2-deoxyglucose remained unal-
Fig. 5. Exposure to high glucose does not inhibit 3-O-methyl-
glucose uptake in ECV304 cells. ECV304 cells were grown to
con£uence and then were incubated for 24 h in medium con-
taining 5.5 (E) or 22 mM glucose (F), and the uptake of 3-O-
methyl-glucose was assayed for the times indicated. Results are
means þ S.E. of three independent experiments, each run on du-
plicate plates.
Fig. 4. Exposure to high glucose does not alter GLUT1 expression or subcellular distribution in ECV 304 cells. (A) ECV304 cells
were grown to con£uence, and incubated in medium with 5.5 or 22 mM glucose for 24 or 48 h. After this time, total RNA was ob-
tained as described in Section 2 and Northern blot assays were performed to detect GLUT1 or L actin. (B) Cells were grown to con-
£uence and then cells were incubated in 5.5 or 22 mM glucose for 24 h. After this time, cells were homogenized and subjected to
membrane subcellular fractionation as described in Section 2, 10 Wg of proteins were loaded in a 10% polyacrylamide gel, and blotted
with antibodies for GLUT1 or L1 integrin.
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tered, phosphorylated 2-deoxyglucose decreased by
59%, and the ratio phosphorylated 2-deoxyglucose/
free 2-deoxyglucose dropped from 4.8 to 1.5 in the
presence of 5.5 mM or 22 mM glucose, respectively
(Fig. 6). These results indicate that 2-deoxyglucose is
less phosphorylated in cells previously subjected to
high glucose concentrations.
4. Discussion
Here we report that glucose uptake by ECV304
endothelial cells decreased in the presence of high
glucose concentration in the medium. The mecha-
nism was reversible and did not involve protein syn-
thesis, changes in glucose transport, on glucose trans-
porter expression or subcellular distribution; rather,
high glucose seems to involve alterations in the rate
of glucose phosphorylation.
In this study, we have shown that ECV304 human
endothelial cells respond to high glucose concentra-
tions by reducing the uptake of 2-deoxyglucose, what
occurs under conditions in which the ratio phos-
phorylated 2-deoxyglucose/free 2-deoxyglucose is
markedly reduced. The dose^response of glucose
for the inhibition of 2-deoxyglucose uptake showed
marked di¡erences compared to previous published
results in other cellular models, such as glial cells
[12], myoblasts L6 [9] or adipocytes 3T3-L1 [20]. In
all, these di¡erent cell types, the half-maximal inhib-
ition of 2-deoxyglucose uptake was obtained between
2 and 4 mM glucose. In contrast, in ECV304 human
endothelial cells, the half-maximal inhibition was ob-
tained near 17 mM glucose, i.e. concentrations 4^8-
fold greater. This further suggests the concept that
the mechanisms underlying the reduction in glucose
uptake by high glucose in ECV304 endothelial cells
are di¡erent than the mechanisms implicated in the
autoregulation of glucose uptake in adipocytes,
muscle or glial cells.
Our results clearly indicate that exposure of
ECV304 endothelial cells to high glucose concentra-
tions did not a¡ect the rate of glucose transport or
the expression of GLUT1 or the subcellular distribu-
tion of this carrier. This is in contrast to what has
been previously reported in many cell types, such as
¢broblasts, adipocytes, muscle or glial cells [9,12,20].
Previous results obtained in endothelial cells or in
isolated microvessels are contradictory. The lack of
e¡ect of high glucose on glucose transport or in the
number of glucose transporters in bovine retinal en-
dothelial cells [38] and in bovine aortic endothelial
cells [39] has been described; no alterations in
GLUT1 mRNA have been detected in human retinal
endothelial cells after exposure to high glucose [40].
In contrast, other reports have substantiated changes
GLUT1 protein, mRNA and in the rate of glucose
transport in bovine brain capillary endothelial cells
in response to glucose starvation [41,42]. Whether the
insensitivity of glucose transport to high glucose is
speci¢c to endothelial cells remains unknown. Fur-
thermore, the nature of the factors that contribute to
insensitivity to high glucose or the possible physio-
logical role of this insensitivity on endothelial cell
function deserves further study.
This is the ¢rst report substantiating an inhibitory
e¡ect of high glucose on glucose phosphorylation, a
step that is catalyzed by hexokinase activity. The
mechanism implicated in the inhibition of hexokinase
activity in ECV304 endothelial cells due to high glu-
cose is unknown. However, the mechanism is rela-
tively slow, since 6 h are required to detect the half-
maximal e¡ect, and is independent of protein syn-
thesis. The fact that the inhibitory e¡ect of high glu-
cose on glucose uptake is slow suggests the non-par-
ticipation of glucose-6-phosphate, known inhibitor of
hexokinases. The lack of e¡ect of high glucose on
total hexokinase activity assayed in vitro might be
Fig. 6. E¡ect of high glucose on the ratio phosphorylated 2-de-
oxyglucose/free 2-deoxyglucose in ECV304 cells. ECV304 cells
were grown to con£uence and then medium was changed to 5.5
(E) or 22 mM glucose (F) for 24 h. After this, cells were incu-
bated for 10 min with 2 WCi [3H]2-deoxyglucose, and both free
2-deoxyglucose or phosphorylated 2-deoxyglucose were meas-
ured as described in Section 2. Results are mean þ S.E. of four
to ¢ve independent experiments.
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explained by the loss or dilution of an inhibitor dur-
ing the preparation of cellular extracts or due to the
disappearance of hexokinase from the precise com-
partment where it acts under in vivo conditions. In
this regard, it has been reported that hexokinase is
regulated via association^dissociation to the outer
membrane of the mitochondria [43]; bound hexokin-
ase results in activation of the enzyme and reduced
ability of glucose-6-phosphate to inhibit the enzyme.
There are conditions, such as cellular transformation
or insulin, in which hexokinase is regulated in vivo
via modi¢cation in the ratio of free/bound hexo-
kinase [44^49]. Whether such a translocation mecha-
nism is operative in response to high glucose deserves
further study. Furthermore, an intriguing possibility
is that the e¡ect of high glucose on glucose phos-
phorylation is a more general phenomenon; in this
regard, the possible e¡ect of high glucose on this step
should be analyzed in cell types other than endothe-
lial cells.
It is likely that glucose-induced reduction in glu-
cose uptake and glucose phosphorylation causes a
drop in the rate of glycolysis. However, this has
not been directly addressed here. In addition, it is
conceivable that preincubation of cells in the pres-
ence of high glucose might lead to alterations in the
rate of other regulatory glycolytic enzymes. Thus,
further studies should evaluate the impact of high
glucose on glycolytic £ux, glucose fate as well as
on the enzyme activities of phosphofructokinase I
or pyruvate kinase.
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